The debate around prescription drug measures in the recently passed U.S. Inflation Reduction Act (IRA), which limit some patients’ out-of-…
There are widespread differences in total factor productivity across producers in the U.S. and around the world. To help explain these…
Alzheimer's disease (AD) affects one in ten people aged 65 or older and is the most expensive disease in the United States. We describe the…
The United States spends substantially more on health care than most developed countries, yet leaves a greater share of the population…
The US spends substantially more on health care per capita than other high-income countries yet leaves a greater share of the population…
A survey of the NEJM Catalyst Insights Council finds strong support globally for government regulation of biopharmaceutical prices.
/publications/achieving-universal-health-insurance-coverage-united-states-addressing-market-failures
The United States spends substantially more on health care than most developed countries, yet leaves a greater share of the population…
Hospitals play a key role in patient outcomes and spending, but efforts to improve their quality are hindered because we do not know…
The U.S. health care system faces unprecedented challenges. Overall life expectancy has improved, but racial and socioeconomic disparities…
Regulators of new products confront a tradeoff between speeding a new product to market and collecting additional product quality…